German scientists making corona virus vaccine reject President Trump’s offer
Berlin: Tensions between the United States and Germany over President Donald Trump’s attempt to buy scientists from a German pharmaceutical company approaching the manufacture of the Corona virus vaccine.
According to the German news agency, German pharmaceutical company ‘Cover Week’ has had significant success in the preparation of the Corona virus vaccine, but there has already been a dispute between Germany and the US over vaccine ownership.
The German newspaper Welt am Zuntag claims that the US president contacted German scientists during the vaccine preparations and was tempted to pay huge sums to get the vaccine. President Trump wanted the proprietary rights of the vaccine so that anyone in the world who needed it would buy it from the United States.
Meanwhile, scientists from German pharmaceutical company CureWeek told local media that we have informed our government about the US President’s rejection. After the discovery of the scientists, the accusation of diplomatic relations between the two countries began.
A branch of the pharmaceutical company ‘Q Week’ is also located in the US city of Houston and the US president has exercised his influence over the same branch. Will hold the meeting.
The German Minister of Health said in a statement on state TV that Germany is not ready to flee, that the vaccine is being developed to serve humanity, whose proprietary rights cannot be assigned to a single individual or country. Against this epidemic we have to fight unity and chance.